BACKGROUND AND AIMS: Alcohol intake is a strong and well established risk factor for oesophageal squamous cell carcinoma (OSCC), but the association with oesophageal adenocarcinoma (OA) or adjacent tumours of the oesophagogastric junction (OGJA), remains unclear. Therefore, the association of alcohol intake with OSCC, OA, and OGJA was determined in nine case-control studies and two cohort studies of the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium (BEACON). MATERIALS AND METHODS: Information was collected on alcohol intake, age, sex, education, body mass index, gastro-oesophageal reflux, and tobacco smoking from each study. Along with 10,854 controls, 1821 OA, and 1837 OGJA, seven studies also collected OSCC cases (n=1016). Study specific ORs and 95% CIs were calculated from multivariate adjusted logistic regression models for alcohol intake in categories compared to non-drinkers. Summary risk estimates were obtained by random effects models. Results No increase was observed in the risk of OA or OGJA for increasing levels of any of the alcohol intake measures examined. ORs for the highest frequency category (≥ 7 drinks per day) were 0.97 (95% CI 0.68 to 1.36) for OA and 0.77 (95% CI = 0.54 to 1.10) for OGJA. Suggestive findings linked moderate intake (eg, 0.5 to <1 drink per day) to decreased risk of OA (OR 0.63, 95% CI 0.41 to 0.99) and OGJA (OR 0.78, 95% CI 0.62 to 0.99). In contrast, alcohol intake was strongly associated with increased risk of OSCC (OR for ≥ 7 drinks per day 9.62, 95% CI 4.26 to 21.71). CONCLUSIONS: In contrast to OSCC, higher alcohol consumption was not associated with increased risk of either OA or OGJA. The apparent inverse association observed with moderate alcohol intake should be evaluated in future prospective studies.
BACKGROUND AND AIMS: Alcohol intake is a strong and well established risk factor for oesophageal squamous cell carcinoma (OSCC), but the association with oesophageal adenocarcinoma (OA) or adjacent tumours of the oesophagogastric junction (OGJA), remains unclear. Therefore, the association of alcohol intake with OSCC, OA, and OGJA was determined in nine case-control studies and two cohort studies of the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium (BEACON). MATERIALS AND METHODS: Information was collected on alcohol intake, age, sex, education, body mass index, gastro-oesophageal reflux, and tobacco smoking from each study. Along with 10,854 controls, 1821 OA, and 1837 OGJA, seven studies also collected OSCC cases (n=1016). Study specific ORs and 95% CIs were calculated from multivariate adjusted logistic regression models for alcohol intake in categories compared to non-drinkers. Summary risk estimates were obtained by random effects models. Results No increase was observed in the risk of OA or OGJA for increasing levels of any of the alcohol intake measures examined. ORs for the highest frequency category (≥ 7 drinks per day) were 0.97 (95% CI 0.68 to 1.36) for OA and 0.77 (95% CI = 0.54 to 1.10) for OGJA. Suggestive findings linked moderate intake (eg, 0.5 to <1 drink per day) to decreased risk of OA (OR 0.63, 95% CI 0.41 to 0.99) and OGJA (OR 0.78, 95% CI 0.62 to 0.99). In contrast, alcohol intake was strongly associated with increased risk of OSCC (OR for ≥ 7 drinks per day 9.62, 95% CI 4.26 to 21.71). CONCLUSIONS: In contrast to OSCC, higher alcohol consumption was not associated with increased risk of either OA or OGJA. The apparent inverse association observed with moderate alcohol intake should be evaluated in future prospective studies.
Authors: Michael B Cook; Farin Kamangar; David C Whiteman; Neal D Freedman; Marilie D Gammon; Leslie Bernstein; Linda M Brown; Harvey A Risch; Weimin Ye; Linda Sharp; Nirmala Pandeya; Penelope M Webb; Anna H Wu; Mary H Ward; Carol Giffen; Alan G Casson; Christian C Abnet; Liam J Murray; Douglas A Corley; Olof Nyrén; Thomas L Vaughan; Wong-Ho Chow Journal: J Natl Cancer Inst Date: 2010-08-17 Impact factor: 13.506
Authors: Lindsay Brown; Paul A Kroon; Dipak K Das; Samarjit Das; Arpad Tosaki; Vincent Chan; Manfred V Singer; Peter Feick Journal: Alcohol Clin Exp Res Date: 2009-06-10 Impact factor: 3.455
Authors: Ai Kubo; Theodore R Levin; Gladys Block; Gregory J Rumore; Charles P Quesenberry; Patricia Buffler; Douglas A Corley Journal: Gastroenterology Date: 2008-11-27 Impact factor: 22.682
Authors: Lesley A Anderson; Marie M Cantwell; R G Peter Watson; Brian T Johnston; Seamus J Murphy; Heather R Ferguson; Jim McGuigan; Harry Comber; John V Reynolds; Liam J Murray Journal: Gastroenterology Date: 2008-12-03 Impact factor: 22.682
Authors: Michael B Cook; Shannon N Wood; Brooks D Cash; Patrick Young; Ruben D Acosta; Roni T Falk; Ruth M Pfeiffer; Nan Hu; Hua Su; Lemin Wang; Chaoyu Wang; Barbara Gherman; Carol Giffen; Cathy Dykes; Veronique Turcotte; Patrick Caron; Chantal Guillemette; Sanford M Dawsey; Christian C Abnet; Paula L Hyland; Philip R Taylor Journal: Clin Gastroenterol Hepatol Date: 2014-08-24 Impact factor: 11.382
Authors: Jennifer Drahos; Qian Xiao; Harvey A Risch; Neal D Freedman; Christian C Abnet; Lesley A Anderson; Leslie Bernstein; Linda Brown; Wong-Ho Chow; Marilie D Gammon; Farin Kamangar; Linda M Liao; Liam J Murray; Mary H Ward; Weimin Ye; Anna H Wu; Thomas L Vaughan; David C Whiteman; Michael B Cook Journal: Int J Cancer Date: 2015-08-26 Impact factor: 7.396
Authors: M B Cook; S Wood; P L Hyland; P Caron; J Drahos; R T Falk; R M Pfeiffer; S M Dawsey; C C Abnet; P R Taylor; C Guillemette; L J Murray; L A Anderson Journal: Andrology Date: 2017-02-27 Impact factor: 3.842
Authors: Aaron P Thrift; Michael B Cook; Thomas L Vaughan; Lesley A Anderson; Liam J Murray; David C Whiteman; Nicholas J Shaheen; Douglas A Corley Journal: Am J Gastroenterol Date: 2014-07-22 Impact factor: 10.864
Authors: Michael R Burgio; John P A Ioannidis; Brett M Kaminski; Eric Derycke; Scott Rogers; Muin J Khoury; Daniela Seminara Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-09-17 Impact factor: 4.254
Authors: Wen-Qing Li; Yikyung Park; Jennifer W Wu; Jian-Song Ren; Alisa M Goldstein; Philip R Taylor; Albert R Hollenbeck; Neal D Freedman; Christian C Abnet Journal: Clin Gastroenterol Hepatol Date: 2013-04-13 Impact factor: 11.382